Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 16.35
+0.63 (4.01%)
Sep 30, 2026, 4:08 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 7.23 billion as of September 30, 2026. Its market cap has decreased by -37.75% in one year.
Market Cap
7.23B
Enterprise Value
5.15B
Revenue
2.68B
Ranking
n/a
PE Ratio
20.59
Stock Price
16.35
ChartMarket Cap Chart
Since April 30, 2015, HKG:6826's market cap has decreased from 9.34B to 7.23B, a decrease of -22.59%. That is a compound annual growth rate of -2.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 7.23B | -28.86% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 9.75B |
| Ascletis Pharma | 9.03B |
| Suzhou Ribo Life Science | 8.72B |
| CStone Pharmaceuticals | 8.19B |
| Alphamab Oncology | 7.80B |
| LongBio Pharma (Suzhou) | 7.62B |
| Lepu Biopharma | 6.87B |
| CARsgen Therapeutics Holdings | 6.85B |